(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-1.32%) $82.74
(6.60%) $2.05
(0.07%) $2 348.80
(-0.35%) $27.44
(4.10%) $959.90
(-0.20%) $0.933
(-0.37%) $10.98
(-0.53%) $0.796
(1.66%) $93.40
-3.42% $ 1.410
Live Chart Being Loaded With Signals
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders...
Stats | |
---|---|
Dzisiejszy wolumen | 4 615.00 |
Średni wolumen | 11 972.00 |
Kapitalizacja rynkowa | 6.25M |
EPS | $0 ( 2024-04-02 ) |
Następna data zysków | ( $0 ) 2024-05-15 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.230 |
ATR14 | $0.0740 (5.25%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-25 | Wright Timothy R | Buy | 21 250 | PTIX Common stock Options |
2024-03-25 | Stein Robert Benjamin | Buy | 75 000 | PTIX Common stock Options |
2024-03-25 | Barrage Khalil | Buy | 22 500 | PTIX Common stock Options |
2024-03-25 | Buell Jennifer | Buy | 75 000 | PTIX Common stock Options |
2024-03-25 | Armen Garo H | Buy | 250 000 | PTIX Common stock Options |
INSIDER POWER |
---|
100.00 |
Last 91 transactions |
Buy: 6 726 731 | Sell: 101 568 933 |
Protagenic Therapeutics, Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Protagenic Therapeutics, Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-28 218.00 (0.00 %) |
EPS: | $-1.150 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-28 218.00 (0.00 %) |
EPS: | $-1.150 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-30.00 (0.00 %) |
EPS: | $-0.830 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-0.310 |
Financial Reports:
No articles found.
Protagenic Therapeutics,
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej